exercise therapy to improve cell count in autologous bone marrow transplantation in hematopoetic cancer
Not Applicable
- Conditions
- Hematopoetic cancer.Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue
- Registration Number
- IRCT20170921036304N2
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 52
Inclusion Criteria
age :16-65 years old
multiple myeloma or Hodgkin disease confirmed by pathology
treatment option : autologous bone marrow transplantation
willing to participation
Exclusion Criteria
no concomitant chronic disease (Hypertension, Diabetes, Chronic Kidney disease)
concomitant orthopedic deficiency interrupting exercise
not willing to do 14 aerobic exercise session in 4 weeks
not willing to do 8 resistance exercise session in 4 weeks
history of hemoglobin level less than 8 g/dl
history of platelet less than 50000/microl
History of fever and neutropenia
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bone marrow sample WBC count for transplant. Timepoint: after 4 weeks of standard pre-transplant treatment ( control group) or 4 weeks exercise in addition to standard pre-transplant treatment ( intervention group). Method of measurement: the number of mononuclear and CD34 cells by the report of pathologist.
- Secondary Outcome Measures
Name Time Method Hospital admission length after transplant. Timepoint: after patients discharge. Method of measurement: admition days based on the hospital documentation.